Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Markets

Marksans Pharma hits 52-week high after USFDA issues EIR for Goa facility

Shares of Marksans Pharma soared up to 1.98 per cent at Rs 220.14 per share on the BSE in Tuesday's intraday trade

By: business-standard.com

Aug 20 2024
20
14068 Views

Marksans Pharma hits 52-week high after USFDA issues EIR for Goa facility

Marksans Pharma hits 52-week high after USFDA issues EIR for Goa facility

Related

Macquarie reaffirms 'outperform' rank to TCS; stock hits 52-week high

Unimech Aerospace Ltd files draft papers with Sebi for Rs 500 cr IPO

Benchmark stocks to rise modestly by year-end, correction unlikely: Poll

Sebi releases new cyber security framework for regulated entities

Haryana-based Innovision files IPO papers with Sebi, eyes Rs 315 cr

Kharif crop sowing rises to 1031.56 lakh hectares

EPFO adds net 19.29 lakh members in June 2024

IPO fee pool to surpass 2023's total; Ola, FirstCry spell gains for bankers

Indices gain amidst fed rate cut optimism; IT, financial stocks lead

INR firm at over two-week high amid positive local equities

P I Industries completes acquisition of UK based Plant Health Care Plc

Board of Sansera Engineering approves fund raising up to Rs 1,200 cr

Macquarie reaffirms 'outperform' rank to TCS; stock hits 52-week high